Literature DB >> 16055491

Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris.

Juan Cosin-Sales1, Juan Carlos Kaski, Michael Christiansen, Paul Kaminski, Claus Oxvig, Michael T Overgaard, Della Cole, David W Holt.   

Abstract

AIMS: To assess, in chronic stable angina (CSA) patients, the relationship among clinical characteristics and cardiovascular risk factors, extent of coronary artery disease (CAD), and pregnancy-associated plasma protein-A (PAPP-A) levels. METHODS AND
RESULTS: We studied 643 CSA patients (63+/-10 years, 482 men) undergoing diagnostic coronary angiography; 97 with angiographically normal coronary arteries or <50% stenosis, 127 with single vessel disease (VD), and 419 with multi-VD. Patients' age, gender, cardiovascular risk factors, body mass index, history of previous myocardial infarction, angina class, left ventricular ejection fraction (LVEF), and treatment were assessed at study entry. PAPP-A levels (mIU/L) were higher in men than in women (6.2+/-2.4 vs. 5.2+/-1.8; P<0.001) and in hypertensive vs. normotensive patients (6.4+/-2.8 vs. 5.8+/-2.1; P=0.01). PAPP-A correlated directly with age (r=0.19, P<0.001) and inversely with LVEF (r=-0.11, P=0.01). Patients with multivessel disease (VD) had higher PAPP-A levels (6.45+/-2.58) than those with single-VD (5.49+/-1.54, P<0.001) or normal coronaries (4.62+/-1.17, P<0.001). Male gender, age, history of a previous MI, hypercholesterolaemia, and PAPP-A levels were independent predictors for the presence of CAD.
CONCLUSION: In CSA patients PAPP-A levels correlate with age, male gender, hypertension, and CAD extent. In the present study, PAPP-A was an independent predictor for the presence and extent of CAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055491     DOI: 10.1093/eurheartj/ehi433

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Candidate biomarkers for the detection of coronary plaque destabilization and rupture.

Authors:  Anand Prasad; Sotirios Tsimikas
Journal:  Curr Atheroscler Rep       Date:  2008-08       Impact factor: 5.113

2.  Association of E-selectin gene polymorphism and serum PAPP-A with carotid atherosclerosis in end-stage renal disease.

Authors:  Marianne Samir M Issac; Alaa Afif; Nadida A Gohar; Nahla A Fawzy Fayek; Bahaa Zayed; Heba Sedrak; Lamiaa Adel Salah El Din
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

3.  PAPP-A as a marker of increased long-term risk in patients with chest pain.

Authors:  Peter A Kavsak; Xuesong Wang; Matthew Henderson; Dennis T Ko; Andrew R MacRae; Allan S Jaffe
Journal:  Clin Biochem       Date:  2009-03-25       Impact factor: 3.281

4.  Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain.

Authors:  Stephan von Haehling; Wolfram Doehner; Ewa A Jankowska; Piotr Ponikowski; Konstantinos Stellos; Valentina O Puntmann; Eike Nagel; Stefan D Anker; Meinrad Gawaz; Boris Bigalke
Journal:  CMAJ       Date:  2013-03-18       Impact factor: 8.262

5.  Pregnancy-associated plasma protein-A (PAPP-A) as a possible biomarker in patients with coronary artery disease.

Authors:  H Gutiérrez-Leonard; E Martínez-Lara; A E Fierro-Macías; V M Mena-Burciaga; M D Ronquillo-Sánchez; E Floriano-Sánchez; N Cárdenas-Rodríguez
Journal:  Ir J Med Sci       Date:  2016-10-11       Impact factor: 1.568

6.  CRP and TNF-α  induce PAPP-A expression in human peripheral blood mononuclear cells.

Authors:  Weiping Li; Hongwei Li; Fusheng Gu
Journal:  Mediators Inflamm       Date:  2012-09-11       Impact factor: 4.711

7.  Insulin-Like Growth Factor Binding Protein 4 Fragments Provide Incremental Prognostic Information on Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Rikke Hjortebjerg; Søren Lindberg; Sune Pedersen; Rasmus Mogelvang; Jan S Jensen; Claus Oxvig; Jan Frystyk; Mette Bjerre
Journal:  J Am Heart Assoc       Date:  2017-03-17       Impact factor: 5.501

8.  Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.

Authors:  Martin Henriksson; Stephen Palmer; Ruoling Chen; Jacqueline Damant; Natalie K Fitzpatrick; Keith Abrams; Aroon D Hingorani; Ulf Stenestrand; Magnus Janzon; Gene Feder; Bruce Keogh; Martin J Shipley; Juan-Carlos Kaski; Adam Timmis; Mark Sculpher; Harry Hemingway
Journal:  BMJ       Date:  2010-01-19

9.  Pregnancy-associated plasma protein A predicts adverse vascular events in patients with coronary heart disease: a systematic review and meta-analysis.

Authors:  Yuehua Li; Chenghui Zhou; Xianliang Zhou; Lihuan Li; Rutai Hui
Journal:  Arch Med Sci       Date:  2013-05-28       Impact factor: 3.318

10.  Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction.

Authors:  Germán Cediel; Ferran Rueda; Claus Oxvig; Teresa Oliveras; Carlos Labata; Oriol de Diego; Marc Ferrer; M Cruz Aranda-Nevado; Judith Serra-Gregori; Julio Núñez; Cosme García; Antoni Bayes-Genis
Journal:  Cardiovasc Diabetol       Date:  2018-04-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.